Biogen BIIB Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Other | $55.4M-15.7% | $65.7M+18.8% | $55.3M+18.2% | $46.8M+59.2% | $29.4M+14.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Biogen break its business down?
- Biogen (BIIB) reports revenue by product across 2 parts — Contract manufacturing, royalty and other revenue and Other. Each is extracted from the segment footnotes and tracked over time.
- Where does Biogen's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Biogen's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
